JP2019511556A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019511556A5 JP2019511556A5 JP2018554375A JP2018554375A JP2019511556A5 JP 2019511556 A5 JP2019511556 A5 JP 2019511556A5 JP 2018554375 A JP2018554375 A JP 2018554375A JP 2018554375 A JP2018554375 A JP 2018554375A JP 2019511556 A5 JP2019511556 A5 JP 2019511556A5
- Authority
- JP
- Japan
- Prior art keywords
- inhalation
- magnesium isoglycyrrhizinate
- lactose
- particle size
- isoglycyrrhizinate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021126412A JP7309791B2 (ja) | 2016-04-15 | 2021-08-02 | イソグリチルリチン酸またはその塩の吸入製剤および呼吸器疾患を治療する薬物の製造におけるそれらの使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610237175 | 2016-04-15 | ||
| CN201610237175.3 | 2016-04-15 | ||
| PCT/CN2017/080583 WO2017177966A1 (zh) | 2016-04-15 | 2017-04-14 | 异甘草酸或其盐的吸入制剂及其在制备治疗呼吸系统疾病药物中的应用 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021126412A Division JP7309791B2 (ja) | 2016-04-15 | 2021-08-02 | イソグリチルリチン酸またはその塩の吸入製剤および呼吸器疾患を治療する薬物の製造におけるそれらの使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019511556A JP2019511556A (ja) | 2019-04-25 |
| JP2019511556A5 true JP2019511556A5 (https=) | 2022-06-23 |
| JP7166929B2 JP7166929B2 (ja) | 2022-11-08 |
Family
ID=60042326
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018554375A Active JP7166929B2 (ja) | 2016-04-15 | 2017-04-14 | イソグリチルリチン酸またはその塩の吸入製剤および呼吸器疾患を治療する薬物の製造におけるそれらの使用 |
| JP2021126412A Active JP7309791B2 (ja) | 2016-04-15 | 2021-08-02 | イソグリチルリチン酸またはその塩の吸入製剤および呼吸器疾患を治療する薬物の製造におけるそれらの使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021126412A Active JP7309791B2 (ja) | 2016-04-15 | 2021-08-02 | イソグリチルリチン酸またはその塩の吸入製剤および呼吸器疾患を治療する薬物の製造におけるそれらの使用 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US20190117568A1 (https=) |
| EP (1) | EP3443954B1 (https=) |
| JP (2) | JP7166929B2 (https=) |
| KR (1) | KR102410183B1 (https=) |
| CN (2) | CN111920785B (https=) |
| AU (1) | AU2017251548B2 (https=) |
| BR (1) | BR112018071208A2 (https=) |
| EA (1) | EA201892350A1 (https=) |
| MX (1) | MX394106B (https=) |
| MY (1) | MY204600A (https=) |
| PH (1) | PH12018502195A1 (https=) |
| SG (2) | SG11201809042SA (https=) |
| WO (1) | WO2017177966A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119345161A (zh) * | 2024-12-25 | 2025-01-24 | 江苏长泰药业股份有限公司 | 一种丙酮酸钠雾化吸入制剂及其制备方法和应用 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4891221A (en) * | 1988-11-23 | 1990-01-02 | Edward Shanborm | Whole blood antiviral process and composition |
| WO2005004913A1 (ja) * | 2003-07-09 | 2005-01-20 | Anges Mg, Inc. | デコイを含む薬学的組成物およびその使用方法 |
| EP1643973A1 (en) | 2003-07-11 | 2006-04-12 | Glaxo Group Limited | Pharmaceutical formulations comprising magnesium stearate |
| CN101023953B (zh) * | 2006-07-24 | 2010-05-12 | 南开大学 | 治疗支气管哮喘的组合物 |
| CN101190232B (zh) * | 2006-11-30 | 2011-08-17 | 江苏正大天晴药业股份有限公司 | 一种注射用异甘草酸镁冻干粉针剂及其制备方法 |
| JP2008222682A (ja) * | 2007-03-15 | 2008-09-25 | Kumamoto Univ | 線維化肺疾患治療薬、気道粘液分泌細胞過形成抑制剤および気道塞栓治療薬 |
| CN101396368B (zh) * | 2007-09-29 | 2010-12-01 | 江苏正大天晴药业股份有限公司 | 异甘草酸或其盐在制备治疗过敏性鼻炎药物中的应用 |
| CN101669962A (zh) * | 2009-09-18 | 2010-03-17 | 杭州市第六人民医院 | 复合甘草酸氨基酸注射液及其制备方法和应用 |
| WO2012026928A1 (en) * | 2010-08-25 | 2012-03-01 | Diacarta Llc | Use of glycyrrhetinic acid, glycyrrhizic acid and related compounds for prevention and/or treatment of pulmonary fibrosis |
| CN103156930A (zh) * | 2011-12-19 | 2013-06-19 | 张亚军 | 一种含芍药和甘草提取物的呼吸道给药制剂 |
| UA115544C2 (uk) * | 2012-03-13 | 2017-11-27 | Респіверт Лімітед | Спосіб підвищення стабільності до хімічного розкладання фармацевтичної композиції та застосування стабілізуючого агента у фармацевтичній коипозиції |
| CN102920936A (zh) * | 2012-09-17 | 2013-02-13 | 陈泉生 | 一种治疗呼吸道疾病的吸盐物及其制作方法 |
| CN104042573A (zh) * | 2014-06-03 | 2014-09-17 | 青岛市市立医院 | 一种异甘草酸镁冻干粉针剂及其制备方法 |
| CN106237297A (zh) * | 2016-08-30 | 2016-12-21 | 吉林紫鑫药业股份有限公司 | 一种用于治疗慢性支气管炎的药物组合物 |
-
2017
- 2017-04-14 SG SG11201809042SA patent/SG11201809042SA/en unknown
- 2017-04-14 JP JP2018554375A patent/JP7166929B2/ja active Active
- 2017-04-14 BR BR112018071208-6A patent/BR112018071208A2/pt not_active Application Discontinuation
- 2017-04-14 US US16/093,087 patent/US20190117568A1/en not_active Abandoned
- 2017-04-14 WO PCT/CN2017/080583 patent/WO2017177966A1/zh not_active Ceased
- 2017-04-14 MY MYPI2018703789A patent/MY204600A/en unknown
- 2017-04-14 MX MX2018012461A patent/MX394106B/es unknown
- 2017-04-14 EA EA201892350A patent/EA201892350A1/ru unknown
- 2017-04-14 CN CN202010842414.4A patent/CN111920785B/zh active Active
- 2017-04-14 EP EP17781942.2A patent/EP3443954B1/en active Active
- 2017-04-14 SG SG10202010192YA patent/SG10202010192YA/en unknown
- 2017-04-14 KR KR1020187033045A patent/KR102410183B1/ko active Active
- 2017-04-14 CN CN201780018629.0A patent/CN109069442B/zh active Active
- 2017-04-14 AU AU2017251548A patent/AU2017251548B2/en active Active
-
2018
- 2018-10-12 PH PH12018502195A patent/PH12018502195A1/en unknown
-
2020
- 2020-08-07 US US16/988,289 patent/US11534398B2/en active Active
-
2021
- 2021-08-02 JP JP2021126412A patent/JP7309791B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4262086B2 (ja) | エーロゾル化用に至適化されたトブラマイシン製剤 | |
| US8840930B2 (en) | Pharmaceutical composition for inhalation | |
| PL190782B1 (pl) | Nowe zastosowanie budesonidu i formoterolu | |
| AU2002319226A1 (en) | Optimised formulation of tobramycin for aerosolization | |
| EP1915129A2 (en) | Pharmaceutical formulations comprising a long-acting beta2-agonist for administration by nebulisation | |
| JP2014525471A (ja) | 咳および咳発作の治療 | |
| EP1272162A1 (en) | Stabilized dry powder formulations | |
| CN116635018A (zh) | 吸入用药物组合物 | |
| IT202000005026A1 (it) | Lattoferrina per uso inalatorio ad azione antivirale | |
| WO2021211858A1 (en) | Inhalable formulation of a solution containing tiotropium bromide and olodaterol | |
| JP7309791B2 (ja) | イソグリチルリチン酸またはその塩の吸入製剤および呼吸器疾患を治療する薬物の製造におけるそれらの使用 | |
| US20050053553A1 (en) | Combined doses of formoterol and fluticasone | |
| JP2021176903A5 (https=) | ||
| JP2019511556A5 (https=) | ||
| CN116196298A (zh) | 一种含格隆铵盐的气雾剂药物组合物及其制备方法与应用 | |
| HK1261173B (en) | Inhaled preparation of isoglycyrrhizic acid or salt thereof, and use of the inhaled preparation | |
| HK1261173A1 (en) | Inhaled preparation of isoglycyrrhizic acid or salt thereof, and use of the inhaled preparation | |
| EA040563B1 (ru) | Применение препарата для ингаляции на основе изоглицирризината магния для лечения заболеваний дыхательной системы | |
| CN118903435A (zh) | 复方药物制剂及其在医药上的应用 | |
| CN115137713A (zh) | 一种两性霉素b雾化吸入制剂及其制备方法 | |
| WO2022166724A1 (zh) | 一种福多司坦吸入用溶液制剂及其制备方法和用途 |